Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-01-25 @ 7:54 AM
Study NCT ID:
NCT00381004
Status:
COMPLETED
Last Update Posted:
2016-01-14
First Post:
2006-09-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Lymphocytic Leukemia | View |